New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2014
07:28 EDTAXLLAxiall management to meet with UBS
Meeting to be held in Chicago on March 12 hosted by UBS.
News For AXLL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 2, 2015
08:50 EDTAXLLAxiall announces departure of Chief Strategy Officer George Biltz
Subscribe for More Information
February 26, 2015
09:22 EDTAXLLAxiall sells Specialty Phosgene Derivatives business assets to Altivia
Subscribe for More Information
09:17 EDTAXLLAxiall signs agreement to sell La Porte facility to Altivia
Axiall signed a definitive agreement to sell its La Porte, Texas, chemical manufacturing facility to ALTIVIA Chemicals. Financial terms of the agreement, which is subject to customary closing processes, were not announced. The transaction is expected to close within 45 days. The Axiall facility at La Porte manufactures phosgene and its derivatives, which are used in the polymer, pharmaceutical and agricultural chemicals industries. ALTIVIA Specialty Chemicals, is a manufacturer and distributor of chemicals used primarily for municipal and industrial water treatment, oil field drilling and production operations, and pulp and paper production.
February 25, 2015
10:01 EDTAXLLOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:39 EDTAXLLAxiall upgraded to Sector Perform from Underperform at RBC Capital
February 20, 2015
10:19 EDTAXLLAxiall price target raised to $55 from $48 at Goldman
Goldman raised Axiall's price target to $55 following the Q4 report and the disclosure it has filed a PLR with the IRS to create the first chlor-alkali MLP. The firm believes the MLP could unlock up to $10 per share in value and reiterates its Buy rating.
February 19, 2015
10:32 EDTAXLLHigh option volume stocks:
Subscribe for More Information
10:26 EDTAXLLAxiall rises as MLP potential discussed during earnings call
Subscribe for More Information
10:17 EDTAXLLAxiall jumps 6% to $49.43 during earnings conference call

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use